Branches of biology

80% Ethanol Hand Sanitizer Now Available from SynCardia Systems, LLC

Monday, April 6, 2020 - 11:13pm

SynCardia is now offering 80% ethanol hand sanitizer for sale in bulk quantities intended for hospitals and other large healthcare organizations as well as food service and federal, state, and local agencies capable of distributing to the areas of greatest need

Key Points: 
  • SynCardia is now offering 80% ethanol hand sanitizer for sale in bulk quantities intended for hospitals and other large healthcare organizations as well as food service and federal, state, and local agencies capable of distributing to the areas of greatest need
    SynCardia Systems, LLC announced today that the company has begun manufacturing and selling an 80% ethanol (alcohol) hand sanitizer.
  • Hand hygiene is an important part of the U.S. response to COVID-19.
  • SynCardia Systems, LLC (Tucson, AZ) is the privately-held manufacturer of the worlds first and only FDA, Health Canada and CE approved temporary Total Artificial Heart.
  • Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency.

Global Induced Pluripotent Stem Cell (iPSC) Industry

Monday, April 6, 2020 - 6:10pm

EXHIBIT 1: Worldwide Publication of hESC and hiPSC Research Papers for the Period 2008-2010, 2011-2013 and 2014-2016

Key Points: 
  • EXHIBIT 1: Worldwide Publication of hESC and hiPSC Research Papers for the Period 2008-2010, 2011-2013 and 2014-2016
    Induced Pluripotent: A Potential Competitor to hESCs?
  • EXHIBIT 3: Global Regenerative Medicine Market Size in US$ Billion for 2019, 2021, 2023 and 2025
    EXHIBIT 5: Global Regenerative Medicines Market by Category: Breakdown (in %) for Biomaterials, Stem Cell Therapies and Tissue Engineering for 2019
    EXHIBIT 6: Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
    EXHIBIT 7: Global Precision Medicine Market (In US$ Billion) for the Years 2018, 2021 & 2024
    EXHIBIT 8: Worldwide Cancer Incidence: Number of New Cancer Cases Diagnosed for 2012, 2018 & 2040
    EXHIBIT 9: Number of New Cancer Cases Reported (in Thousands) by Cancer Type: 2018
    EXHIBIT 10: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    EXHIBIT 11: Rising Diabetes Prevalence Presents Opportunity for iPSCs Market: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
    Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for iPSCs Market
    EXHIBIT 13: New Gene-Editing Tools Spur Interest and Investments in Genetics, Driving Lucrative Growth Opportunities for iPSCs: Total VC Funding (In US$ Million) in Genetics for the Years 2014, 2015, 2016, 2017 and 2018
    Table 1: Induced Pluripotent Stem Cell (iPSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    Table 2: Induced Pluripotent Stem Cell (iPSC) Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
    Table 3: Vascular Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
    Table 4: Vascular Cells (Cell Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
    Table 5: Cardiac Cells (Cell Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
    Table 6: Cardiac Cells (Cell Type) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
    Table 7: Neuronal Cells (Cell Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
    Table 8: Neuronal Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
    Table 9: Liver Cells (Cell Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
    Table 10: Liver Cells (Cell Type) Market Share Breakdown by Region/Country: 2019 VS 2025
    Table 11: Immune Cells (Cell Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
    Table 12: Immune Cells (Cell Type) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
    Table 13: Other Cell Types (Cell Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
    Table 14: Other Cell Types (Cell Type) Market Percentage Share Distribution by Region/Country: 2019 VS 2025
    Table 15: Cellular Reprogramming (Research Method) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
    Table 16: Cellular Reprogramming (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
    Table 17: Cell Culture (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025
    Table 18: Cell Culture (Research Method) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025
    Table 19: Cell Differentiation (Research Method) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
    Table 20: Cell Differentiation (Research Method) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
    Table 21: Cell Analysis (Research Method) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
    Table 22: Cell Analysis (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
    Table 23: Cellular Engineering (Research Method) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2
    Table 24: Cellular Engineering (Research Method) Market Share Breakdown by Region/Country: 2019 VS 2025
    Table 25: Other Research Methods (Research Method) World Market by Region/Country in US$ Thousand: 2018 to 2025
    Table 26: Other Research Methods (Research Method) Market Share Distribution in Percentage by Region/Country: 2019 VS 2025
    Table 27: Drug Development & Toxicology Testing (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025
    Table 28: Drug Development & Toxicology Testing (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2019 VS 2025
    Table 29: Academic Research (Application) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025
    Table 30: Academic Research (Application) Market Share Shift across Key Geographies: 2019 VS 2025
    Table 31: Regenerative Medicine (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025
    Table 32: Regenerative Medicine (Application) Market Share Breakdown by Region/Country: 2019 VS 2025
    Table 33: Other Applications (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025
    Table 34: Other Applications (Application) Share Breakdown Review by Region/Country: 2019 VS 2025
    Table 35: United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Cell Type: 2018 to 2025
    Table 36: United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
    Table 37: United States Induced Pluripotent Stem Cell (iPSC) Market Estimates and Projections in US$ Thousand by Research Method: 2018 to 2025
    Table 38: United States Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
    Table 39: United States Induced Pluripotent Stem Cell (iPSC) Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025
    Table 40: Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown in the United States by Application: 2019 VS 2025
    Table 41: Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025
    Table 42: Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025
    Table 43: Canadian Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025
    Table 44: Induced Pluripotent Stem Cell (iPSC) Market in Canada: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025
    Table 45: Canadian Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    Table 46: Canadian Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
    Table 48: Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
    Table 50: Japanese Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
    Table 51: Japanese Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
    Table 52: Induced Pluripotent Stem Cell (iPSC) Market Share Shift in Japan by Application: 2019 VS 2025
    Table 54: Chinese Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025
    Table 56: Chinese Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025
    Table 57: Chinese Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
    Table 58: Chinese Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025
    Table 59: European Induced Pluripotent Stem Cell (iPSC) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    Table 60: European Induced Pluripotent Stem Cell (iPSC) Market Share Shift by Region/Country: 2019 VS 2025
    Table 61: European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025
    Table 62: European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
    Table 63: European Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025
    Table 64: European Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
    Table 65: European Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    Table 66: European Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
    Table 67: Induced Pluripotent Stem Cell (iPSC) Market in France by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    Table 68: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
    Table 69: Induced Pluripotent Stem Cell (iPSC) Market in France by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025
    Table 70: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
    Table 71: Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025
    Table 72: French Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2
    Table 73: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Cell Type for the Period 2018-2025
    Table 74: German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
    Table 75: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Research Method for the Period 2018-2025
    Table 76: German Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
    Table 77: Induced Pluripotent Stem Cell (iPSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025
    Table 78: Induced Pluripotent Stem Cell (iPSC) Market Share Distribution in Germany by Application: 2019 VS 2025
    Table 80: Italian Induced Pluripotent Stem Cell (iPSC) Market by Cell Type: Percentage Breakdown of Sales for 2019 and 2025
    Table 82: Italian Induced Pluripotent Stem Cell (iPSC) Market by Research Method: Percentage Breakdown of Sales for 2019 and 2025
    Table 83: Italian Demand for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
    Table 84: Italian Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Application: 2019 VS 2025
    Table 86: United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
    Table 88: United Kingdom Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
    Table 89: United Kingdom Demand Estimates and Forecasts for Induced Pluripotent Stem Cell (iPSC) in US$ Thousand by Application: 2018 to 2025
    Table 90: Induced Pluripotent Stem Cell (iPSC) Market Share Shift in the United Kingdom by Application: 2019 VS 2025
    Table 91: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018-2025
    Table 92: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Cell Type: 2019 VS 2025
    Table 93: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018-2025
    Table 94: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Breakdown by Research Method: 2019 VS 2025
    Table 95: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025
    Table 96: Rest of Europe Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025
    Table 97: Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Cell Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    Table 98: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Cell Type: 2019 VS 2025
    Table 99: Induced Pluripotent Stem Cell (iPSC) Market in Asia-Pacific by Research Method: Estimates and Projections in US$ Thousand for the Period 2018-2025
    Table 100: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Research Method: 2019 VS 2025
    Table 101: Induced Pluripotent Stem Cell (iPSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025
    Table 102: Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Share Analysis: A 7-Year Perspective by Application for 2019 and 2025
    Table 103: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Cell Type: 2018 to 2025
    Table 104: Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Cell Type for 2019 and 2025
    Table 105: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Estimates and Forecasts in US$ Thousand by Research Method: 2018 to 2025
    Table 106: Induced Pluripotent Stem Cell (iPSC) Market in Rest of World: Percentage Share Breakdown of Sales by Research Method for 2019 and 2025
    Table 107: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025
    Table 108: Rest of World Induced Pluripotent Stem Cell (iPSC) Market Share Analysis by Application: 2019 VS 2025

Convalescent Plasma Collected in the Carolinas

Monday, April 6, 2020 - 8:19pm

The blood product, known as convalescent plasma , may have antibodies that can help those critically ill from COVID-19 to fight the virus.

Key Points: 
  • The blood product, known as convalescent plasma , may have antibodies that can help those critically ill from COVID-19 to fight the virus.
  • Blood donation is a wonderful way to give back and this convalescent plasma program is another way to help save lives in your community, said Delisa English, CEO and President of The Blood Connection.
  • If you have recovered from COVID-19, please consider donating plasma to help with the research that will help others to fight this virus.
  • If you are interested in donating convalescent plasma, please make an appointment at a center near you by calling The Blood Connection at (864)751-1168.

InventHelp Presents Early Warning System for Heat-Related Illnesses (MOA-232)

Monday, April 6, 2020 - 4:45pm

"I thought that this idea could help to reduce the incidence of heat stroke."

Key Points: 
  • "I thought that this idea could help to reduce the incidence of heat stroke."
  • He developed the patent-pending POP to serve as a detection system for hyperthermia (heat stroke).
  • The device helps the individual to recognize signs and symptoms of heat-related illness.
  • 18-MOA-232, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

Allen Institute Announces New Phase Of Neuroscience Research

Monday, April 6, 2020 - 4:00pm

SEATTLE, April 6, 2020 /PRNewswire/ -- The Allen Institute today announced new phases of research for its largest division, the Allen Institute for Brain Science, as well as a leader hired to direct a new neuroscience-related division of the Institute.

Key Points: 
  • SEATTLE, April 6, 2020 /PRNewswire/ -- The Allen Institute today announced new phases of research for its largest division, the Allen Institute for Brain Science, as well as a leader hired to direct a new neuroscience-related division of the Institute.
  • Established in 2003, the Allen Institute for Brain Science has grown to more than 300 researchers and staff working in two broad research programs.
  • In this new phase, the Allen Institute for Brain Science will focus solely on brain cell types and connectivity research.
  • The MindScope Program, which seeks to understand how the brain's neural circuits produce the sense of vision, will also move into a new phase of discovery and will transition out of the Allen Institute for Brain Science to become a separate program of the Allen Institute.

Enzymes Market Size, Share & Trends Analysis Report By Application, By Product, By Source, By Region And Segment Forecasts, 2020 - 2027

Monday, April 6, 2020 - 3:30pm

Enzymes Market Size, Share & Trends Analysis Report By Application (Industrial Enzymes, Specialty Enzymes), By Product (Carbohydrase, Proteases, Lipases), By Source, By Region, And Segment Forecasts, 2020 - 2027

Key Points: 
  • Enzymes Market Size, Share & Trends Analysis Report By Application (Industrial Enzymes, Specialty Enzymes), By Product (Carbohydrase, Proteases, Lipases), By Source, By Region, And Segment Forecasts, 2020 - 2027
    The global enzymes market size is expected to reach USD 17.2 billion by 2027, registering a CAGR of 7.1% over the forecast period.
  • Enzymes are also used as feed additives in the animal feed industry.Phytase, protease, and carbohydrase are used extensively in the animal feed industry.
  • Increasing demand for the product in the animal feed industry due to their multi-functional attributes is anticipated to boost the enzymes market growth.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

iReceptor Plus to Offer Tools and Infrastructure for Sharing Antibody and T-cell Receptor Sequencing Data From COVID-19 Patients

Monday, April 6, 2020 - 3:15pm

RAMAT GAN, Israel, April 6, 2020 /PRNewswire/ -- The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to facilitate the sharing and analyses of antibody and T-cell receptor sequencing (AIRR-seq) data from COVID-19 patients as soon as these data become available.

Key Points: 
  • RAMAT GAN, Israel, April 6, 2020 /PRNewswire/ -- The international iReceptor Plus consortium is offering the technology tools and infrastructure developed within the EU-funded project, to facilitate the sharing and analyses of antibody and T-cell receptor sequencing (AIRR-seq) data from COVID-19 patients as soon as these data become available.
  • Among others, the iReceptor Plus Platform is at the stage where it is ready to incorporate data and be used by its industrial partner 10x Genomics .
  • Additionally, the iReceptor Plus project works in close coordination with the Adaptive Immune Receptor Repertoire (AIRR) Community .
  • Together with the AIRR Community, iReceptor Plus is mapping the different efforts in producing AIRR-seq data in the context of COVID-19.

Rafarma Establishes Advisory Board, Appoints First Member and Will Acquire Additional Patents and Intellectual Property

Monday, April 6, 2020 - 5:15pm

Rafarma will also enter into non-dilutive agreements with Dr. Laskavy to acquire all of his intellectual property and patents, including multiple United States, Australian and other International patents which include patents for cancer treatment and stem cell therapy.

Key Points: 
  • Rafarma will also enter into non-dilutive agreements with Dr. Laskavy to acquire all of his intellectual property and patents, including multiple United States, Australian and other International patents which include patents for cancer treatment and stem cell therapy.
  • The addition of Dr. Laskavy enables Rafarma to add multiple treatment options to the companys current Medicinal Marijuana treatment protocols.
  • Rafarma CEO Vladimir Dolgolenko stated: We feel the addition of Dr. Vladislav Laskavy to our advisory board will assist us in providing truly unique treatment options at our cutting-edge detox spas.
  • Rafarma is also excited to implement its own stem cell activation therapy using Dr. Laskavys patented techniques throughout the spas.

OncoSec Collaborates with Providence Cancer Institute to Conduct First-in-Human Trial of OncoSec's CORVax12, an Investigational Vaccine to Prevent COVID-19, Combining an Enhanced "Spike" DNA Sequence and TAVO™

Monday, April 6, 2020 - 2:00pm

CORVax12 is designed to drive a coordinated vaccine response, capable of drawing upon the innate, adaptive humoral, and adaptive cellular arms.

Key Points: 
  • CORVax12 is designed to drive a coordinated vaccine response, capable of drawing upon the innate, adaptive humoral, and adaptive cellular arms.
  • We believe this multi-pronged innate, adaptive and cellular immune response is likely to be important in generating a robust anti-viral response.
  • Importantly, we believe the delivery of CORVax12 using OncoSec's electroporation system may allow for highly effective DNA transfer to drive this investigational vaccine."
  • Dr. Leidner continued, "Providence is among the U.S.'s largest, not-for-profit network of hospitals and includes 51 hospitals in Alaska, Washington, Oregon, Montana and California.

Worldwide RNA Sequencing Market to 2028 - Hybridization of Technologies Presents Opportunities - ResearchAndMarkets.com

Monday, April 6, 2020 - 4:53pm

The RNA sequencing market generated $1,064.6 million in revenue in 2019, in terms of value.

Key Points: 
  • The RNA sequencing market generated $1,064.6 million in revenue in 2019, in terms of value.
  • Key Questions Answered in this Report:
    What are the major market drivers, restraining factors, and opportunities in the global RNA sequencing market?
  • What are the underlying structures resulting in the emerging trends within the global RNA sequencing market?
  • What are the key patents obtained by the companies for various technologies in the global RNA sequencing market?